Multicenter Study of the Molecular Basis of Thalassemia Intermedia in Different Ethnic Populations

REFERENCES

• Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Org 2001; 79(8)704–712
   PubMed Web of Science ®Google Scholar
• Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann NY Acad Sci 1998; 850: 251–269
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. Thalassaemia Syndromes, 4th. Blackwell Science Publishers, Oxford 2001
   Google Scholar
• Modell B, Berdoukas V. The Clinical Approach to Thalassaemia. Grune & Stratton, London 1984; 354–378
   Google Scholar
• Kazazian HH, Jr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol 1990; 27(3)209–228
   PubMed Web of Science ®Google Scholar
• Thein SL. Genetic insights into the clinical diversity of β-thalassaemia. Br J Hematol 2004; 124(3)264–274
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001; 2(4)245–255
   PubMed Web of Science ®Google Scholar
• Camaschella C, Mazza U, Roetto A, Gottardi E, Parziale A, Travi M, Fattore S, Bacchiega D, Fiorelli G, Cappellini MD. Genetic interactions in thalassemia intermedia: analysis of β-mutations, α-genotype, γ-promoters, and β-LCR hypersensitive sites 2 and 4 in Italian patients. Am J Hematol 1995; 48(2)82–87
   PubMed Web of Science ®Google Scholar
• Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalshekar N, Smith JC, Markham AE. Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17(7)2503–2516
   PubMed Web of Science ®Google Scholar
• Old JM, Khan SN, Verma I, Fucharoen S, Kleanthous M, Ioannou P, Kotea N, Fisher C, Riazuddin S, Saxena R, Winichagoon P, Kyriacou K, Al-Quobaili F, Khan B. A multicenter study in order to further define the molecular basis of β-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. Hemoglobin 2001; 25(4)397–407
   PubMed Web of Science ®Google Scholar
• Losekoot M, Fodde R, Harteveld CL, van Heeren HV, Giordano PC, Went LN, Bernini LF. Homozygous β+thalassaemia owing to a mutation in the cleavage-polyadenylation sequence of the human β globin gene. J Med Genet 1991; 28(4)252–255
   PubMed Web of Science ®Google Scholar
• Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, Goosens M. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum Mut 1992; 1(3)229–239
   PubMedGoogle Scholar
• Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74(12)5463–5467
   PubMed Web of Science ®Google Scholar
• Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994; 46(3)208–213
   PubMed Web of Science ®Google Scholar
• Bowden DK, Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of α thalassaemia. Br J Haematol 1992; 81(1)104–108
   PubMed Web of Science ®Google Scholar
• Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA 1981; 78(8)5041–5045
   PubMed Web of Science ®Google Scholar
• Higgs DR, Goodbourn SE, Lamb J, Clegg JB, Weatherall DJ, Proudfoot NJ. α-Thalassaemia caused by a polyadenylation signal mutation. Nature 1983; 306(5941)398–400
   PubMed Web of Science ®Google Scholar
• Kyriacou K, Kyrri A, Kalogirou E, Ph Vasiliades, Angastiniotis M, Ioannou PA, Kleanthous M. Hb Bart's levels in cord blood and α-thalassemia in Cyprus. Hemoglobin 2000; 24(3)171–180
   PubMed Web of Science ®Google Scholar
• Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol 1989; 32(1)66–69
   PubMed Web of Science ®Google Scholar
• Baysal E, Indrak K, Bozkurt G, Berkalp G, Aritkan E, Old JM, Ioannou P, Angastiniotis M, Droushiotou A, Yuregir GT, Kilinç Y, Huisman THJ. The β-thalassaemia mutations in the population of Cyprus. Br J Haematol 1992; 81(4)607–609
   PubMed Web of Science ®Google Scholar
• Kotea N, Ramasawmy R, Lu CY, Fa NS, Gerard N, Beesoon S, Ducrocq R, Surrun SK, Nagel RL, Krishnamoorthy R. Spectrum of β thalassemia mutations and their linkage to β-globin gene haplotypes in the Indo-Mauritians. Am J Hematol 2000; 63(1)11–15
   PubMed Web of Science ®Google Scholar
• Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of β-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol 1991; 78(2)242–247
   PubMed Web of Science ®Google Scholar
• Varawalla NY, Old JM, Weatherall DJ. Rare β-thalassaemia mutations in Asian Indians. Br J Hematol 1991; 79(4)640–644
   PubMed Web of Science ®Google Scholar
• Verma IC, Saxena R, Jain PK, Thomas E. Regional distribution of β-thalassemia mutations in India. Hum Genet 1997; 100(1)109–113
   PubMed Web of Science ®Google Scholar
• Saxena R, Jain PK, Thomas E, Verma IC. Prenatal diagnosis of β-thalassemia: experience in a developing country. Prenat Diagn 1998; 18(1)1–7
   PubMed Web of Science ®Google Scholar
• Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin 2001; 25(1)35–43
   PubMed Web of Science ®Google Scholar
• Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25(3)285–296
   PubMed Web of Science ®Google Scholar
• Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, Giordano PC. β-Thalassemia intermedia from southern Iran: IVS-II-I (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26(2)147–154
   PubMed Web of Science ®Google Scholar
• Thein SL, Winichagoon P, Hesketh C, Best S, Fucharoen S, Wasi P, Weatherall DJ. The molecular basis of β-thalassemia in Thailand: application to prenatal diagnosis. Am J Hum Genet 1990; 47(3)369–375
   PubMed Web of Science ®Google Scholar
• Winichagoon P, Fucharoen S, Thonglairoam V, Tanapotiwirut V, Wasi P. β-Thalassemia in Thailand. Ann NY Acad Sci 1990; 612:31–42.
   Google Scholar
• Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia: molecular biology and clinical medicine. Hemoglobin 1997; 21(4)299–319
   PubMed Web of Science ®Google Scholar
• Winichagoon P, Thonglairoam V, Fuchareon S, Wilairat P, Fukumaki Y, Wasi P. Severity differences in β-thalassaemia/Haemoglobin E syndromes: implication of genetic factors. Br J Haematol 1993; 83(4)633–639
   PubMed Web of Science ®Google Scholar
• Khan S, Riazuddin S. Molecular characterization of β-thalassemia in Pakistan. Hemoglobin 1998; 22(4)333–345
   PubMed Web of Science ®Google Scholar
• Winichagoon P, Fucharoen S, Chen P, Wasi P. Genetic factors affecting clinical severity in β-thalassemia syndromes. J Pediatr Hematol Oncol 2000; 22(6)573–580
   PubMed Web of Science ®Google Scholar
• Galanello R, Cao A. Relationship between genotype and phenotype. Thalassemia intermedia. Ann NY Acad Sci 1998; 850: 325–333
   PubMed Web of Science ®Google Scholar
• Fonesca SF, Kerbauy J, Escrivao C, Figueiredo MS, Cancado R, Arruda VR, Saad ST, Costa FF. Genetic analysis of β-thalassemia major and β-thalassemia intermedia in Brazil. Hemoglobin 1998; 22(3)197–207
   PubMed Web of Science ®Google Scholar
• Ho PJ, Hall GW, Luo LY, Weatherall DJ, Thein SL. β Thalassaemia intermedia: is it possible consistently to predict phenotype from genotype. Br J Hematol 1998; 100(1)70–78
   PubMed Web of Science ®Google Scholar
• Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37(1)12–20
   PubMed Web of Science ®Google Scholar
• Colah R, Nadkarni A, Gorashakar A, Phanasgaonkar S, Surve R, Subramaniam PG, Bondge N, Pujari K, Ghosh K, Mohanty D. Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India. Blood Cells Mol Dis 2004; 33(2)153–157
   PubMed Web of Science ®Google Scholar
• Garewal G, Fearon CW, Warren TC, Marwah N, Marwah RK, Mahadik C, Kazazian HH. The molecular basis of β-thalassaemia in Punjabi and Maharashtrian Indians includes a multi-locus etiology involving triplicated α-globin gene. Br J Hematol 1994; 86(2)372–376
   PubMed Web of Science ®Google Scholar
• Nadkarni A, Gorakshakar AC, Lu CY, Krishnamoorthy R, Ghosh K, Colah R, Mohanty D. Molecular pathogenesis and clinical variability of β-thalassemia syndromes among Indians. Am J Hematol 2001; 68(2)75–80
   PubMed Web of Science ®Google Scholar
• Mastropietro F, Modiano G, Cappabianca M, Foglietta E, D'Asero C, Mezzabotta M, Ponzini D, Maffei L, Amato A, Lerone M, Grisanti P, Di Biagio P, Rinaldi S, Bianco I. Factors regulating Hb F synthesis in thalassemic diseases. BMC Blood Disord 2002; 2(1)2
   PubMedGoogle Scholar
• Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC. Response to hydroxyurea treatment in Iranian transfusion-dependent β-thalassemia patients. Haematologica. 2004; 89(10)1172–1178
   PubMed Web of Science ®Google Scholar
• Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol 2005; 27(7)380–385
   PubMed Web of Science ®Google Scholar